Company / Return on Equity (ROE)
NEPHROS INC Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
11.7%
FY2025
5-year range
-127.1% / 11.7%
FY2021-FY2025
Trend
+162.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) has increased for 3 consecutive years, from -127.1% in FY2022 to 11.7% in FY2025.
Based on SEC 10-K filings.
11.7% in FY2025 with a 5-year CAGR of +47.8%.
Improved from -80.0% to 11.7% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +138.8pp
- 5-Year Change
- +47.8pp
- 10-Year Change
- -
Key checks
Key Insights
- NEPHROS INC's return on equity (roe) has grown for 3 consecutive years.
- In FY2025, return on equity (roe) increased 162.1% year-over-year.
- Lowest return on equity (roe) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 11.7% | +162.1% |
| FY2024 | -18.8% | +76.5% |
| FY2023 | -80.0% | +37.0% |
| FY2022 | -127.1% | -284.2% |
| FY2021 | -33.1% | +8.5% |
| FY2020 | -36.1% | +46.9% |
| FY2019 | -68.0% | +24.1% |
| FY2018 | -89.6% | +42.4% |
| FY2017 | -155.5% | +65.8% |
| FY2016 | -454.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026